Global Ophthalmic Viscoelastic Agent Market Research Report 2023

Publication ID:

PB502238966

Publication Date:

February 3, 2023

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Highlights
The global Ophthalmic Viscoelastic Agent market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Ophthalmic Viscoelastic Agent is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Ophthalmic Viscoelastic Agent is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Ophthalmic Viscoelastic Agent include Alcon Inc, Shanghai Haohai Biological Technology, Bausch & Lomb Inc, Abbott Medical Optics,Inc., LG Life Sciences, Johnson & Johnson Vision, Zeiss, Ellex Medical Laser Limited and Huvitz Co., Ltd., etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Viscoelastic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Viscoelastic Agent.
The Ophthalmic Viscoelastic Agent market size, estimations, and forecasts are provided in terms of sales volume (K Grams) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Ophthalmic Viscoelastic Agent market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Viscoelastic Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Alcon Inc
Shanghai Haohai Biological Technology
Bausch & Lomb Inc
Abbott Medical Optics,Inc.
LG Life Sciences
Johnson & Johnson Vision
Zeiss
Ellex Medical Laser Limited
Huvitz Co., Ltd.
Iridex Corp.
Lumenis Ltd.
Nidek Co. Ltd
Topcon Corporation
Visionix Ltd
Eyebright Medical
Segment by Type
Cohesive Viscoelastic
Low Viscosity Dispersion Viscoelastic
Segment by Application
Cataract Surgery
Myopia Surgery
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ophthalmic Viscoelastic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ophthalmic Viscoelastic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Ophthalmic Viscoelastic Agent Market Overview
1.1 Product Overview and Scope of Ophthalmic Viscoelastic Agent
1.2 Ophthalmic Viscoelastic Agent Segment by Type
1.2.1 Global Ophthalmic Viscoelastic Agent Market Value Comparison by Type (2023-2029)
1.2.2 Cohesive Viscoelastic
1.2.3 Low Viscosity Dispersion Viscoelastic
1.3 Ophthalmic Viscoelastic Agent Segment by Application
1.3.1 Global Ophthalmic Viscoelastic Agent Market Value by Application: (2023-2029)
1.3.2 Cataract Surgery
1.3.3 Myopia Surgery
1.3.4 Other
1.4 Global Ophthalmic Viscoelastic Agent Market Size Estimates and Forecasts
1.4.1 Global Ophthalmic Viscoelastic Agent Revenue 2018-2029
1.4.2 Global Ophthalmic Viscoelastic Agent Sales 2018-2029
1.4.3 Global Ophthalmic Viscoelastic Agent Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Ophthalmic Viscoelastic Agent Market Competition by Manufacturers
2.1 Global Ophthalmic Viscoelastic Agent Sales Market Share by Manufacturers (2018-2023)
2.2 Global Ophthalmic Viscoelastic Agent Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Ophthalmic Viscoelastic Agent Average Price by Manufacturers (2018-2023)
2.4 Global Ophthalmic Viscoelastic Agent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Ophthalmic Viscoelastic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ophthalmic Viscoelastic Agent, Product Type & Application
2.7 Ophthalmic Viscoelastic Agent Market Competitive Situation and Trends
2.7.1 Ophthalmic Viscoelastic Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ophthalmic Viscoelastic Agent Players Market Share by Revenue
2.7.3 Global Ophthalmic Viscoelastic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ophthalmic Viscoelastic Agent Retrospective Market Scenario by Region
3.1 Global Ophthalmic Viscoelastic Agent Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Ophthalmic Viscoelastic Agent Global Ophthalmic Viscoelastic Agent Sales by Region: 2018-2029
3.2.1 Global Ophthalmic Viscoelastic Agent Sales by Region: 2018-2023
3.2.2 Global Ophthalmic Viscoelastic Agent Sales by Region: 2024-2029
3.3 Global Ophthalmic Viscoelastic Agent Global Ophthalmic Viscoelastic Agent Revenue by Region: 2018-2029
3.3.1 Global Ophthalmic Viscoelastic Agent Revenue by Region: 2018-2023
3.3.2 Global Ophthalmic Viscoelastic Agent Revenue by Region: 2024-2029
3.4 North America Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.4.1 North America Ophthalmic Viscoelastic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Ophthalmic Viscoelastic Agent Sales by Country (2018-2029)
3.4.3 North America Ophthalmic Viscoelastic Agent Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.5.1 Europe Ophthalmic Viscoelastic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Ophthalmic Viscoelastic Agent Sales by Country (2018-2029)
3.5.3 Europe Ophthalmic Viscoelastic Agent Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Ophthalmic Viscoelastic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Ophthalmic Viscoelastic Agent Sales by Country (2018-2029)
3.6.3 Asia Pacific Ophthalmic Viscoelastic Agent Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.7.1 Latin America Ophthalmic Viscoelastic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Ophthalmic Viscoelastic Agent Sales by Country (2018-2029)
3.7.3 Latin America Ophthalmic Viscoelastic Agent Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Ophthalmic Viscoelastic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Ophthalmic Viscoelastic Agent Sales by Country (2018-2029)
3.8.3 Middle East and Africa Ophthalmic Viscoelastic Agent Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ophthalmic Viscoelastic Agent Sales by Type (2018-2029)
4.1.1 Global Ophthalmic Viscoelastic Agent Sales by Type (2018-2023)
4.1.2 Global Ophthalmic Viscoelastic Agent Sales by Type (2024-2029)
4.1.3 Global Ophthalmic Viscoelastic Agent Sales Market Share by Type (2018-2029)
4.2 Global Ophthalmic Viscoelastic Agent Revenue by Type (2018-2029)
4.2.1 Global Ophthalmic Viscoelastic Agent Revenue by Type (2018-2023)
4.2.2 Global Ophthalmic Viscoelastic Agent Revenue by Type (2024-2029)
4.2.3 Global Ophthalmic Viscoelastic Agent Revenue Market Share by Type (2018-2029)
4.3 Global Ophthalmic Viscoelastic Agent Price by Type (2018-2029)
5 Segment by Application
5.1 Global Ophthalmic Viscoelastic Agent Sales by Application (2018-2029)
5.1.1 Global Ophthalmic Viscoelastic Agent Sales by Application (2018-2023)
5.1.2 Global Ophthalmic Viscoelastic Agent Sales by Application (2024-2029)
5.1.3 Global Ophthalmic Viscoelastic Agent Sales Market Share by Application (2018-2029)
5.2 Global Ophthalmic Viscoelastic Agent Revenue by Application (2018-2029)
5.2.1 Global Ophthalmic Viscoelastic Agent Revenue by Application (2018-2023)
5.2.2 Global Ophthalmic Viscoelastic Agent Revenue by Application (2024-2029)
5.2.3 Global Ophthalmic Viscoelastic Agent Revenue Market Share by Application (2018-2029)
5.3 Global Ophthalmic Viscoelastic Agent Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Alcon Inc
6.1.1 Alcon Inc Corporation Information
6.1.2 Alcon Inc Description and Business Overview
6.1.3 Alcon Inc Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Alcon Inc Ophthalmic Viscoelastic Agent Product Portfolio
6.1.5 Alcon Inc Recent Developments/Updates
6.2 Shanghai Haohai Biological Technology
6.2.1 Shanghai Haohai Biological Technology Corporation Information
6.2.2 Shanghai Haohai Biological Technology Description and Business Overview
6.2.3 Shanghai Haohai Biological Technology Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Shanghai Haohai Biological Technology Ophthalmic Viscoelastic Agent Product Portfolio
6.2.5 Shanghai Haohai Biological Technology Recent Developments/Updates
6.3 Bausch & Lomb Inc
6.3.1 Bausch & Lomb Inc Corporation Information
6.3.2 Bausch & Lomb Inc Description and Business Overview
6.3.3 Bausch & Lomb Inc Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bausch & Lomb Inc Ophthalmic Viscoelastic Agent Product Portfolio
6.3.5 Bausch & Lomb Inc Recent Developments/Updates
6.4 Abbott Medical Optics,Inc.
6.4.1 Abbott Medical Optics,Inc. Corporation Information
6.4.2 Abbott Medical Optics,Inc. Description and Business Overview
6.4.3 Abbott Medical Optics,Inc. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Medical Optics,Inc. Ophthalmic Viscoelastic Agent Product Portfolio
6.4.5 Abbott Medical Optics,Inc. Recent Developments/Updates
6.5 LG Life Sciences
6.5.1 LG Life Sciences Corporation Information
6.5.2 LG Life Sciences Description and Business Overview
6.5.3 LG Life Sciences Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.5.4 LG Life Sciences Ophthalmic Viscoelastic Agent Product Portfolio
6.5.5 LG Life Sciences Recent Developments/Updates
6.6 Johnson & Johnson Vision
6.6.1 Johnson & Johnson Vision Corporation Information
6.6.2 Johnson & Johnson Vision Description and Business Overview
6.6.3 Johnson & Johnson Vision Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson Vision Ophthalmic Viscoelastic Agent Product Portfolio
6.6.5 Johnson & Johnson Vision Recent Developments/Updates
6.7 Zeiss
6.6.1 Zeiss Corporation Information
6.6.2 Zeiss Description and Business Overview
6.6.3 Zeiss Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zeiss Ophthalmic Viscoelastic Agent Product Portfolio
6.7.5 Zeiss Recent Developments/Updates
6.8 Ellex Medical Laser Limited
6.8.1 Ellex Medical Laser Limited Corporation Information
6.8.2 Ellex Medical Laser Limited Description and Business Overview
6.8.3 Ellex Medical Laser Limited Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ellex Medical Laser Limited Ophthalmic Viscoelastic Agent Product Portfolio
6.8.5 Ellex Medical Laser Limited Recent Developments/Updates
6.9 Huvitz Co., Ltd.
6.9.1 Huvitz Co., Ltd. Corporation Information
6.9.2 Huvitz Co., Ltd. Description and Business Overview
6.9.3 Huvitz Co., Ltd. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Huvitz Co., Ltd. Ophthalmic Viscoelastic Agent Product Portfolio
6.9.5 Huvitz Co., Ltd. Recent Developments/Updates
6.10 Iridex Corp.
6.10.1 Iridex Corp. Corporation Information
6.10.2 Iridex Corp. Description and Business Overview
6.10.3 Iridex Corp. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Iridex Corp. Ophthalmic Viscoelastic Agent Product Portfolio
6.10.5 Iridex Corp. Recent Developments/Updates
6.11 Lumenis Ltd.
6.11.1 Lumenis Ltd. Corporation Information
6.11.2 Lumenis Ltd. Ophthalmic Viscoelastic Agent Description and Business Overview
6.11.3 Lumenis Ltd. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Lumenis Ltd. Ophthalmic Viscoelastic Agent Product Portfolio
6.11.5 Lumenis Ltd. Recent Developments/Updates
6.12 Nidek Co. Ltd
6.12.1 Nidek Co. Ltd Corporation Information
6.12.2 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Description and Business Overview
6.12.3 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Product Portfolio
6.12.5 Nidek Co. Ltd Recent Developments/Updates
6.13 Topcon Corporation
6.13.1 Topcon Corporation Corporation Information
6.13.2 Topcon Corporation Ophthalmic Viscoelastic Agent Description and Business Overview
6.13.3 Topcon Corporation Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Topcon Corporation Ophthalmic Viscoelastic Agent Product Portfolio
6.13.5 Topcon Corporation Recent Developments/Updates
6.14 Visionix Ltd
6.14.1 Visionix Ltd Corporation Information
6.14.2 Visionix Ltd Ophthalmic Viscoelastic Agent Description and Business Overview
6.14.3 Visionix Ltd Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Visionix Ltd Ophthalmic Viscoelastic Agent Product Portfolio
6.14.5 Visionix Ltd Recent Developments/Updates
6.15 Eyebright Medical
6.15.1 Eyebright Medical Corporation Information
6.15.2 Eyebright Medical Ophthalmic Viscoelastic Agent Description and Business Overview
6.15.3 Eyebright Medical Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Eyebright Medical Ophthalmic Viscoelastic Agent Product Portfolio
6.15.5 Eyebright Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ophthalmic Viscoelastic Agent Industry Chain Analysis
7.2 Ophthalmic Viscoelastic Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ophthalmic Viscoelastic Agent Production Mode & Process
7.4 Ophthalmic Viscoelastic Agent Sales and Marketing
7.4.1 Ophthalmic Viscoelastic Agent Sales Channels
7.4.2 Ophthalmic Viscoelastic Agent Distributors
7.5 Ophthalmic Viscoelastic Agent Customers
8 Ophthalmic Viscoelastic Agent Market Dynamics
8.1 Ophthalmic Viscoelastic Agent Industry Trends
8.2 Ophthalmic Viscoelastic Agent Market Drivers
8.3 Ophthalmic Viscoelastic Agent Market Challenges
8.4 Ophthalmic Viscoelastic Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Alcon Inc
Shanghai Haohai Biological Technology
Bausch & Lomb Inc
Abbott Medical Optics,Inc.
LG Life Sciences
Johnson & Johnson Vision
Zeiss
Ellex Medical Laser Limited
Huvitz Co., Ltd.
Iridex Corp.
Lumenis Ltd.
Nidek Co. Ltd
Topcon Corporation
Visionix Ltd
Eyebright Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂